St. Jude general counsel heads back to old firm
Steve Tight, the former VP, general counsel and chief compliance officer at St. Jude Medical’s (NYSE:STJ) atrial fibrillation division in St. Paul, Minn., left the company and rejoined the law firm of Fredrikson & Byron.
Tight joined St. Jude Medical in 2009, prior to which he had been with Fredrikson & Byron for nearly a decade.
Tight now is an officer in Fredrikson’s corporate law, mergers & acquisitions, private equity and venture capital, and life sciences, according to the Fredrikson & Byron’s website.
Tight’s departure from St. Jude comes in the midst of the company’s Riata lead recall scandal. Some researchers have credited the devices were tied to 22 deaths related to short-circuits between high-voltage components.
In an ongoing battle to preserve its newer leads from the recalled Riata,
St. Jude earlier this month touted low failure rates for Durata, Riata ST Optim heart device leads.
AspenBio has new marketing consultant
AspenBio, an in vitro diagnostic company, named Miquel Vernet as a consultant for the company as it prepares for European commercialization.
Vernet, a European-based sales and marketing veteran, will work closely with the company’s chief commercial officer Don Hurd, AspenBio said.
AspenBio expects to land CE Mark approval in the European market for its appendicitis diagnostic test by the end of the year, according to the press release.
Premier’s board of directors become members of the GPMR committee
Hospital and health system executives named Premier’s 4 board directors to the Group Purchasing & Member Relations stockholder committee.
Premier’s GPMR committee has 23 expert executives, advising the board on financial improvement programs, including group purchasing and resource utilization.
MRI Interventions names Robert Korn VP of global sales & marketing
Korn most recently was regional sales director at Medtronic’s (NYSE:MDT) Surgical Technologies business, with a focus on growing sales of neurosurgical and navigation products. Prior to that, Korn worked at Codman as midwest division sales manager and at Johnson & Johnson’s (NYSE:JNJ) neuroscience division.
Korn will focus on the on-going commercialization of MRI’s FDA-cleared ClearPoint system, the company said.
Orthofix’s president of global orthopedics business resigns
Orthofix’s (NSDQ:OFIX) president of global orthopedics business Luigi Ferrari left the company to be CEO of Limacorporate S.p.a. in Udine, Italy, after 2 years in the position.
Ferrari previously was president of International orthopedic fixation and VP of Europe at Orthofix. Robert Vaters, the company’s president and CEO, will assume Mr. Ferrari’s operational responsibilities.
Titan Spine named Marcus Klarl as VP of sales for Europe
Klarl was most recently responsible for the increase in sales of the company’s M6 Cervical and Lumbar Artificial Discs for Spinal Kinetics in the German market.